Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
Trial details
- Registry ID
- NCT07287189
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsNCT07287189 | MSLE | Phase 2 | Active not recruiting | 2027-03-31Estimated |
| An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101NCT06867107 | MSLE | Phase 2 | Recruiting | 2027-09-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |